Skip to search formSkip to main contentSkip to account menu

RO3244794

Known as: R-3-(4-fluoro-phenyl)-2-(5-(4-fluoro-phenyl)-benzofuran-2-ylmethoxycarbonylamino)-propionic acid 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

BenzofuransPropionates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Differential action of beraprost isomers on prostacyclin (IP) receptors and PPARβ in pulmonary arteries
Background: Prostacyclin analogues are used to treat pulmonary arterial hypertension (PAH). Oral beraprost-314d, currently… 
2013
2013
Differential actions of the prostacyclin analogues treprostinil and iloprost and the selexipag metabolite, MRE-269 (ACT-333679) in rat small pulmonary arteries and veins.
2012
2012
The COX-2/PGI2 Receptor Axis Plays an Obligatory Role in Mediating the Cardioprotection Conferred by the Late Phase of Ischemic Preconditioning
Background Pharmacologic studies with cyclooxygenase-2 (COX-2) inhibitors suggest that the late phase of ischemic preconditioning… 
2011
2011
Evidence for a Second Receptor for Prostacyclin on Human Airway Epithelial Cells That Mediates Inhibition of CXCL9 and CXCL10 Release
Herein we provide evidence for the coexpression of two distinct prostacyclin (PGI2) receptors (IP) on BEAS-2B human airway… 
2007
2007
ONO-54918-07, a stable prostacyclin analogue, mimics the effect of prostaglandin PGE1 on NG108-15 cells
The aim of this study was to explore the effect of 0NO-54918-07, a stable prostacyclin analogue, on the current–voltage (IV… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)